Moneycontrol.comNatco Pharma inks pact with MabxienceIBNLive.comThree of these products -Trastuzumab, Bevacizumab, Rituximab belong to the oncology segment, while Etanercept is for auto-immune disease, Natco said in a statement. Natco's obligations…
ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small …MarketWatch (press release)Rituximab, azathioprine, methotrexate, or mycophenolate mofetil therapy are also used, but these drugs are associated with an increased risk of infec…
RTT NewsFall in Avastin sales and strong franc hurt Roche financialsPharma TimesThe firm's top-selling drug in the quarter was MabThera/Rituxan (rituximab), for non-Hodgkin's lymphoma and chronic lymphocytic leukaemia as well as rheumatoid arth…
Biogen Idec (BIIB) Shares Given a "Neutral" Rating by JPMorgan Chase & Co …LocalizedUSAIt includes BG-12, Daclizumab, Fampridine, GA101, Humanized Anti-CD20 MAb (ocrelizumab), Lixiavaptan, Long-Acting rFactor IX and PEGylated interferon…
NICE recommends RoActemra for early use in arthritisInPharmThis updates its previous guidance (TA198) from last August, which said RoActemra should only be used for patients with RA if there has been an inadequate response to one or more TNF inhibitors…
Four growth drivers beyond patent for pharma companies like Sun Pharma, SanofiEconomic TimesAhead of the Pack: When launched in India in 2007, Dr Reddy's Reditux, a brand of cancer drug rituximab, was the first biosimilar of Roche's $6 billion …
Neue Daten, die auf dem 5. gemeinsamen Kongress von ECTRIMS und ACTRIMS …Business Wire (Pressemitteilung)Zu den Highlights gehören: DAC HYP ist eine einmal monatlich subkutan verabreichte Daclizumab-Formulierung zur Behandlung von RRMS, die sich in …
Stem Cell Transplantation With Reduced-Intensity Preparative Therapy And …The MDS Beacon… stem cell transplants with partially mismatched donors were successful in patients with MDS and acute myeloid leukemia after reduced-intensity preparative the…
Mucocutaneous Paraneoplastic Syndromes Associated With Hematologic MalignanciesCancer NetworkTreatment guidelines are not available, but case series point to the use of rituximab (Rituxan) as well as corticosteroids and various other immunomodulating a…
Samenvatting: Gegevens gepresenteerd op het vijfde gezamenlijke driejaarlijkse …Business Wire (persbericht)… (fampridine met verlengde afgifte), evenals twee experimentele stoffen in de late fase, het orale geneesmiddel BG-12 (dimethyl fumaraat) en…